Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonnei.
Anti-Bacterial Agents
/ pharmacology
Australia
Azithromycin
/ pharmacology
Ciprofloxacin
/ pharmacology
Drug Resistance, Multiple, Bacterial
/ genetics
Dysentery, Bacillary
/ diagnosis
England
Genetics, Population
Genome, Bacterial
/ genetics
Genomics
/ methods
Genotype
Geography
Global Health
Humans
Microbial Sensitivity Tests
/ methods
Phylogeny
Polymorphism, Single Nucleotide
Shigella sonnei
/ classification
United States
Whole Genome Sequencing
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
11 05 2021
11 05 2021
Historique:
received:
29
10
2020
accepted:
23
03
2021
entrez:
12
5
2021
pubmed:
13
5
2021
medline:
2
6
2021
Statut:
epublish
Résumé
Shigella sonnei is the most common agent of shigellosis in high-income countries, and causes a significant disease burden in low- and middle-income countries. Antimicrobial resistance is increasingly common in all settings. Whole genome sequencing (WGS) is increasingly utilised for S. sonnei outbreak investigation and surveillance, but comparison of data between studies and labs is challenging. Here, we present a genomic framework and genotyping scheme for S. sonnei to efficiently identify genotype and resistance determinants from WGS data. The scheme is implemented in the software package Mykrobe and tested on thousands of genomes. Applying this approach to analyse >4,000 S. sonnei isolates sequenced in public health labs in three countries identified several common genotypes associated with increased rates of ciprofloxacin resistance and azithromycin resistance, confirming intercontinental spread of highly-resistant S. sonnei clones and demonstrating the genomic framework can facilitate monitoring the spread of resistant clones, including those that have recently emerged, at local and global scales.
Identifiants
pubmed: 33976138
doi: 10.1038/s41467-021-22700-4
pii: 10.1038/s41467-021-22700-4
pmc: PMC8113504
doi:
Substances chimiques
Anti-Bacterial Agents
0
Ciprofloxacin
5E8K9I0O4U
Azithromycin
83905-01-5
Banques de données
figshare
['10.6084/m9.figshare.13072646']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2684Subventions
Organisme : Wellcome Trust
ID : A/106690/A/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R020787/1
Pays : United Kingdom
Références
Epidemiol Infect. 2020 May 04;148:e180
pubmed: 32364094
Front Microbiol. 2018 Mar 27;9:592
pubmed: 29636749
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
Nat Commun. 2019 Oct 23;10(1):4828
pubmed: 31645551
PLoS Med. 2016 Aug 02;13(8):e1002055
pubmed: 27483136
Swiss Med Wkly. 2018 Aug 22;148:w14645
pubmed: 30141522
Nat Genet. 2012 Sep;44(9):1056-9
pubmed: 22863732
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
mSphere. 2016 Dec 21;1(6):
pubmed: 28028547
Emerg Infect Dis. 2016 Sep;22(9):1545-53
pubmed: 27532625
Bull World Health Organ. 1999;77(8):651-66
pubmed: 10516787
Genome Med. 2014 Nov 20;6(11):90
pubmed: 25422674
Emerg Infect Dis. 2016 Nov;22(11):1948-1952
pubmed: 27767929
N Engl J Med. 2019 Dec 19;381(25):2477-2479
pubmed: 31851807
Epidemiol Infect. 2013 Dec;141(12):2568-75
pubmed: 23425681
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32718957
Antimicrob Agents Chemother. 2003 Feb;47(2):727-34
pubmed: 12543684
Infect Control Hosp Epidemiol. 2019 Jun;40(6):649-655
pubmed: 31012399
PLoS Genet. 2020 Jul 9;16(7):e1008931
pubmed: 32644999
J Clin Microbiol. 2020 Mar 25;58(4):
pubmed: 31969425
Nucleic Acids Res. 2020 Jan 8;48(D1):D517-D525
pubmed: 31665441
Nat Commun. 2014 Sep 01;5:4812
pubmed: 25176035
Microb Genom. 2019 May;5(5):
pubmed: 31099740
Wellcome Open Res. 2019 Dec 2;4:191
pubmed: 32055708
Nat Commun. 2018 Apr 13;9(1):1462
pubmed: 29654279
Microb Genom. 2018 Mar;4(3):
pubmed: 29583113
Euro Surveill. 2019 May;24(22):
pubmed: 31164190
Clin Infect Dis. 2014 Oct;59(7):933-41
pubmed: 24958238
Lancet. 2018 Feb 24;391(10122):801-812
pubmed: 29254859
Microb Genom. 2015 Dec 24;1(6):e000042
pubmed: 28348825
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17522-7
pubmed: 24082120
Clin Infect Dis. 2019 Oct 15;69(9):1535-1544
pubmed: 30615105
Genome Res. 2020 Jan;30(1):138-152
pubmed: 31809257
Nucleic Acids Res. 2019 Jun 20;47(11):5539-5549
pubmed: 31076776
Lancet Infect Dis. 2015 Aug;15(8):913-21
pubmed: 25936611
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
J Clin Microbiol. 2002 Apr;40(4):1538-40
pubmed: 11923391
Clin Microbiol Infect. 2017 Nov;23(11):845-853
pubmed: 28389276
Foods. 2020 Aug 01;9(8):
pubmed: 32752159
Euro Surveill. 2019 Mar;24(13):
pubmed: 30940315
Sci Rep. 2018 May 9;8(1):7389
pubmed: 29743642
J Med Microbiol. 2020 Nov;69(11):1303-1307
pubmed: 33048044
Clin Infect Dis. 2016 Aug 1;63(3):380-6
pubmed: 27090985
J Antimicrob Chemother. 2017 Sep 1;72(9):2496-2502
pubmed: 28591819
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Commun. 2016 Oct 05;7:12827
pubmed: 27703135
Nucleic Acids Res. 2005 Nov 07;33(19):6445-58
pubmed: 16275786
Nat Commun. 2014 Nov 19;5:5471
pubmed: 25407023
BMC Infect Dis. 2009 Dec 15;9:204
pubmed: 20003464